BMO Forecasts Bleak Results For Micron Technology

Micron Technology (NASDAQ: MU) is expected to report its fiscal fourth quarter results on September 29 after the market closes. Analysts expect revenues to come in at $6.69 billion, almost down a quarter from the $9.5 billion estimate they were expecting over the summer. The consensus estimate for net income also dropped significantly to $1.4 billion, down from $3.2 billion over the same time period.

Analysts’ price targets have also declined over the last six months, with the average 12-month price target dropping from $104 in June to $70 today. Micron currently has 37 analysts covering the stock, with six having strong buy ratings, 20 have buy ratings, nine analysts having hold ratings, and the last two analysts have sell ratings on the stock.

In BMO Capital Markets’ earnings preview note, they reiterate their outperform rating but cut their 12-month price target to $80 from $85, saying that their thesis will “be given a severe test over the next two quarters or so.”

They add that the reason they are keeping their outperform rating on the stock even with their thesis being tested is that they believe the industry will be able to demonstrate CapEx discipline while expecting there to be a better supply and demand balance in 2023. BMO also commented that it they believe that the risk versus reward is heavily skewed to the upside, given their downside support is at $45 as this is the company’s trailing book value per share.

With Micron already pre-announcing their results, BMO says that based on their research, the outlook for DRAM and NAND flash over the “near to medium term” is very bleak and are forecasting that Micron will see a double-digit price decline for both DRAM and NAND for the next two quarters with the possibility that it continues.

BMO believes this to be the case for a variety of reasons, which include “very poor demand in the majority of the end markets, from handsets to PCs, to incremental weakness/excess inventory in other markets such as data center as well.”

With this, they expect revenues to come in at $6.71 billion, down 22% sequentially, and earnings per share of $1.31. Specifically, they expect DRAM revenues to come in at $4.64 billion, down 26%, and the average selling price to be down 15%. Lastly, they expect this segment to have 42.1% gross margins, down from 50.8% last quarter.

While for the Trade NAND segment, they forecast revenues to be $1.93 billion, down 16%, with average selling prices down 8% sequentially. They expect gross margins of 32%, versus the 37.5% margins Micron saw last quarter.

With these forecasts, BMO has elected to lower their fiscal 2022 and 2023 estimates which you can see below.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

SSR Mining Walks Away From a World Class Gold-Copper Project

Why More Canadians Are Starting to Think About Leaving | Jesse Day

Instead of Waiting, This Gold Developer Went Bigger | Kenneth McLeod – Sonoro Gold

Recommended

Nord Drills 61,389 g/t Silver Over 0.30 Metres at Castle East

Mercado Minerals Targets District Scale Silver Play With San Dimas Land Grab

Related News

Eldorado Gold: Analyst Ratings Unchanged Despite Production Beats

Eldorado Gold (TSX: ELD) released their Q2’20 preliminary results earlier this week, which included production...

Saturday, July 11, 2020, 08:30:00 AM

Precious Metals: Canaccord Comments On Record Capital Returns From Producers

Recently, Canaccord put out a note titled, “Record return of capital and building cash.” Within,...

Tuesday, September 7, 2021, 04:47:00 PM

Snap Sees Consensus Target Slammed Down To $20 Following Q2 Results

Snap Inc. (NYSE: SNAP) this morning reported its second quarter financial results. The company announced...

Friday, July 22, 2022, 01:30:00 PM

Canaccord Lowers Aurora Cannabis Price Target To $5 Following Q2 Earnings

On February 10th, Aurora Cannabis (TSX: ACB) reported its fiscal second quarter 2022 results. The...

Sunday, February 13, 2022, 05:16:00 PM

Vireo Health: Canaccord Reiterates After Q4 Results

Last week, Vireo Health (CSE: VREO) released their fourth quarter and year-end 2020 financial results....

Monday, March 29, 2021, 04:03:00 PM